Brain CancerFeaturedNeurology·June 3, 2016·3 min readInvestigational Immunotherapy Drug Shrinks Tumors in High Risk Neuroblastoma PatientsResearchers report neuroblastoma tumors shrank in 80 percent of newly diagnosed, high risk patients involved in a clinical trail of an immunotherapy treatment.Read More